证券记录 · 已归档季度
EW
Edwards Lifesciences Corporation · Healthcare · Medical - Devices
24被追踪持有人
-1Δ持有人
280.60M持有股份
$21.82B报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -4.0% ·
股份流向 -1.3% ·
净新建仓位 -8.3%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 14.87M | $1.28B | n/a | −2 |
| Q2 2026 | 163 | -6 | 423.46M | $38.23B | +2 | −9 |
| Q1 2026 | 173 | +2 | 408.99M | $32.75B | +6 | −5 |
| Q4 2025 | 170 | 0 | 441.50M | $37.63B | +2 | −1 |
| Q3 2025 | 24 | -1 | 280.60M | $21.82B | +1 | −3 |
| Q2 2025 | 23 | 0 | 232.09M | $18.15B | n/a | n/a |
| Q1 2025 | 20 | -1 | 112.98M | $8.18B | n/a | −1 |
| Q4 2024 | 21 | +1 | 116.40M | $8.61B | +1 | n/a |
| Q3 2024 | 19 | +1 | 77.58M | $5.12B | +2 | −1 |
| Q2 2024 | 18 | n/a | 60.09M | $5.55B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 70.36M | +0.5% | $5.47B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 54.29M | -2.4% | $4.22B | 0.1% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 50.12M | n/a | $3.90B | 0.1% | n/c | 1 | SEC ↗ ×38 |
| 4 | State Street Global Advisors ✦ (被动) | 25.62M | -0.1% | $1.99B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 20.80M | +4.9% | $1.62B | 0.3% | ▲ Add | 6 | SEC ↗ ×9 |
| 6 | Fidelity (FMR) ✦ | 14.58M | +476.7% | $1.13B | 0.1% | ▲ Add | 2 | SEC ↗ ×5 |
| 7 | Geode Capital Management ✦ (被动) | 12.84M | +0.9% | $993.49M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 6.51M | n/a | $506.23M | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 9 | Citadel Advisors ✦ | 4.23M | -66.7% | $329.32M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 10 | Marshall Wace ✦ | 3.57M | -48.3% | $277.37M | 0.3% | ▼ Trim | 6 | SEC ↗ ×4 |
| 11 | PRIMECAP Management ✦ | 3.52M | +2.2% | $274.01M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 12 | Viking Global Investors ✦ | 3.07M | 新增 | $238.69M | 0.6% | New | 1 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 2.88M | n/a | $223.94M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 14 | AQR Capital Management ✦ | 2.08M | +114.5% | $161.05M | 0.1% | ▲ Add | 6 | SEC ↗ ×6 |
| 15 | Millennium Management ✦ | 1.78M | -73.4% | $138.41M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 1.36M | +55.6% | $105.73M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 858.84K | -0.1% | $66.79M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | Point72 Asset Management ✦ | 732.06K | -75.9% | $56.93M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 572.25K | -1.8% | $44.50M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 20 | Arrowstreet Capital ✦ | 281.97K | +83.2% | $21.93M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 247.42K | -21.8% | $19.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 180.31K | -59.5% | $14.02M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 72.20K | +32.8% | $5.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 33.46K | -22.7% | $2.60M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Viking Global Investors | $238.69M | 0.6% |
已清仓
| Norges Bank | $580.64M | 曾为 0.1% |
| Renaissance Technologies | $81.37M | 曾为 0.1% |
| D. E. Shaw & Co. | $13.39M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 4 持有人, 229.24K 股份, $319,498 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 08
Lippis Daniel J.
Officer · 619 股 · $53,017
Sep 11
Lippis Daniel J.
Officer · 619 股 · $54,169
Aug 31
Dahl Andrew M.
Officer · 544 股 · $49,534
Aug 28
Bruls Annette
Officer · 2.64K 股 · $237,907
Aug 26
Markowitz Wayne
Officer · 1.24K 股 · $113,417
Aug 26
Chopra Daveen
Officer · 1.15K 股 · $105,893
Aug 26
Chopra Daveen
Officer · 30.65K 股 · $2.79M
Aug 11
Lippis Daniel J.
Officer · 619 股 · $56,967
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据